Filed 26d ago· May 8, 2026
41 days to disclose
Donald J. Trump
RPOTUSFlorida
↑bought
Boston Scientific
BSX
$1K-$15K
−27.0% vs S&P 500
Trade dateMar 28, 2026
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
























































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 26d ago | ![]() Donald J. Trump RPOTUSFlorida | ↑bought | Boston Scientific BSX | Mar 28, 2026 41 days to disclose | Bad buy·−$1.9K-23.8% −27.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 26d ago | ![]() Donald J. Trump RPOTUSFlorida | ↑bought | Boston Scientific BSX | Mar 18, 2026 51 days to disclose · 6 past 45-day window | Bad buy·−$57.2K-32.7% −33.6% vs S&P 500 | $100K-$250K midpoint $175K |
May 8, 2026 26d ago | ![]() Donald J. Trump RPOTUSFlorida | ↑bought | Boston Scientific BSX | Mar 17, 2026 52 days to disclose · 7 past 45-day window | Bad buy·−$244.7K-32.6% −31.9% vs S&P 500 | $500K-$1M midpoint $750K |
May 8, 2026 26d ago | ![]() Donald J. Trump RPOTUSFlorida | ↓sold | Boston Scientific BSX | Feb 23, 2026 74 days to disclose · 29 past 45-day window | Flat·+0.0% −6.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Boston Scientific BSX Common Stock | Feb 10, 2026 27 days to disclose | Bad buy·−$2.8K-35.4% −31.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2026 3mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Boston Scientific BSX Common Stock | Jan 30, 2026 14 days to disclose | Bad buy·−$3.9K-48.7% −44.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Boston Scientific BSX | Dec 29, 2025 18 days to disclose | Bad buy·−$16.2K-49.9% −45.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 13, 2026 4mo ago | ![]() John Boozman RSenateArkansas | ↓sold | Boston Scientific BSX ⚑ Healthcare · Veterans' Affairs | Dec 17, 2025 27 days to disclose | Flat·+0.0% −3.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Dec 24, 2025 19 days to disclose | Flat·+0.0% −4.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Boston Scientific BSX Common Stock | Nov 18, 2025 27 days to disclose | Bad buy·−$4.1K-51.7% −49.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Boston Scientific BSX Common Stock ⚑ Healthcare · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Boston Scientific BSX Common Stock ⚑ Healthcare · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Bad buy·−$4.2K-52.4% −55.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Boston Scientific BSX Common Stock ⚑ Healthcare · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2025 6mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Boston Scientific BSX Common Stock | Oct 17, 2025 32 days to disclose | Bad buy·−$4.1K-51.7% −55.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2025 6mo ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Boston Scientific BSX Common Stock ⚑ Healthcare · Ways and Means | Oct 28, 2025 19 days to disclose | Flat·+0.0% +2.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Boston Scientific BSX Common Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Boston Scientific BSX Common Stock ⚑ Healthcare · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Boston Scientific BSX Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$3.6K-44.8% −44.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Jul 31, 2025 14 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Boston Scientific BSX Common Stock ⚑ Healthcare · Health, Employment, Labor, and Pensions | Dec 11, 2024 245 days to disclose · 200 past 45-day window | Bad buy·−$3.8K-47.2% −51.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 10, 2025 10mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Jun 26, 2025 14 days to disclose | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 10, 2025 10mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Jun 11, 2025 29 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Boston Scientific BSX Common Stock | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 6, 2025 12mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | May 13, 2025 24 days to disclose | Flat·+0.0% +12.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Boston Scientific BSX Common Stock | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Apr 28, 2025 8 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Boston Scientific BSX Common Stock | Mar 3, 2025 44 days to disclose | Bad buy·−$4.3K-54.3% −53.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Mar 17, 2025 21 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Feb 24, 2025 10 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | ![]() John Boozman RSenateArkansas | ↑bought | Boston Scientific BSX ⚑ Healthcare · Veterans' Affairs | Feb 13, 2025 21 days to disclose | Bad buy·−$4.4K-54.8% −56.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | ![]() John R. Curtis RSenateUtah | ↓sold | Boston Scientific BSX ⚑ Healthcare · Commerce, Science, and Transportation | Dec 4, 2023 11 days to disclose | Missed gain·−$1.1K-13.3% +43.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Boston Scientific BSX | Oct 3, 2023 29 days to disclose | Good buy·+$1.6K+20.4% −48.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Boston Scientific BSX | Sep 13, 2023 29 days to disclose | Bad buy·−$3.2K-9.8% −21.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2023 2.6y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Boston Scientific BSX | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Boston Scientific BSX | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 24, 2023 2.9y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Boston Scientific BSX | May 31, 2023 24 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 24, 2023 2.9y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Boston Scientific BSX | May 30, 2023 25 days to disclose | Bad buy·−$421-5.3% −22.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Boston Scientific BSX | May 1, 2023 18 days to disclose | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Boston Scientific BSX | Apr 19, 2023 30 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 10, 2023 3.1y ago | ![]() John R. Curtis RSenateUtah | ↓sold | Boston Scientific BSX ⚑ Healthcare · Commerce, Science, and Transportation | Apr 26, 2023 14 days to disclose | Flat·+0.0% +12.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2023 3.1y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Boston Scientific BSX | Mar 29, 2023 30 days to disclose | Flat·+0.0% +16.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 13, 2023 3.2y ago | ![]() John R. Curtis RSenateUtah | ↓sold | Boston Scientific BSX ⚑ Healthcare · Commerce, Science, and Transportation | Feb 23, 2023 18 days to disclose | Missed gain·−$2.5K-31.6% +46.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 5, 2022 3.6y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Oct 24, 2022 12 days to disclose | Flat·+0.0% +15.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 29, 2022 3.6y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Oct 21, 2022 8 days to disclose | Flat·+0.0% +17.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 29, 2022 3.6y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Oct 21, 2022 8 days to disclose | Flat·+0.0% +17.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 24, 2022 3.6y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Boston Scientific BSX | Sep 28, 2022 26 days to disclose | Good buy·+$1.8K+22.2% +2.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 9, 2022 4.4y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | Boston Scientific BSX | Dec 16, 2021 24 days to disclose | price pending | $1K-$15K midpoint $8K |
Aug 12, 2021 4.8y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Aug 6, 2021 6 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2021 4.8y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Aug 3, 2021 9 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2021 4.8y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Aug 3, 2021 9 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2021 4.8y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Aug 3, 2021 9 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2021 4.8y ago | ![]() Alan S. Lowenthal —HouseCalifornia-47 | ↓sold | Boston Scientific BSX | Aug 3, 2021 9 days to disclose | Flat·+0.0% +10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 6, 2021 4.9y ago | ![]() John R. Curtis RSenateUtah | ↑bought | Boston Scientific BSX ⚑ Healthcare · Commerce, Science, and Transportation | Jun 22, 2021 14 days to disclose | Good buy·+$3.3K+41.6% −27.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Boston Scientific BSX ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Good buy·+$3.8K+48.1% −23.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Boston Scientific BSX ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Good buy·+$3.8K+48.1% −23.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 15, 2021 5.0y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Boston Scientific BSX ⚑ Healthcare · Ways and Means | May 20, 2021 26 days to disclose | Good buy·+$3.8K+48.1% −23.8% vs S&P 500 | $1K-$15K midpoint $8K |